Curis
CRIS
#10192
Rank
ยฃ20.4 M
Marketcap
ยฃ0.51
Share price
11.11%
Change (1 day)
-47.66%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -ยฃ24.78 Million

According to Curis's latest financial reports the company's current earnings are ยฃ11.65 Million. In 2024 the company made an earning of -ยฃ31.51 Million, an increase over its 2023 earnings that were of -ยฃ33.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ24.78 Million-21.35%
2024 -ยฃ31.51 Million-5.77%
2023 -ยฃ33.44 Million-13.1%
2022 -ยฃ38.48 Million27.52%
2021 -ยฃ30.18 Million65.09%
2020 -ยฃ18.28 Million-9.1%
2019 -ยฃ20.11 Million-4.73%
2018 -ยฃ21.11 Million-41.95%
2017 -ยฃ36.35 Million-14.37%
2016 -ยฃ42.45 Million3.55%
2015 -ยฃ41 Million271.52%
2014 -ยฃ11.04 Million76.64%
2013 -ยฃ6.25 Million
2011 -ยฃ5.31 Million27.76%
2010 -ยฃ4.16 Million-43.87%
2009 -ยฃ7.4 Million-23.44%
2008 -ยฃ9.67 Million56.66%
2007 -ยฃ6.17 Million-16.71%
2006 -ยฃ7.41 Million-36.92%
2005 -ยฃ11.74 Million156.25%
2004 -ยฃ4.59 Million-37.24%
2003 -ยฃ7.31 Million-93.34%
2002 -ยฃ0.11 Billion86.79%
2001 -ยฃ58.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.50 B-31,404.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.87 B-28,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ45.58 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.69 B-2,990.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ18.24 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA